optimix circular reasonings

The auditors' job is to audit the accounts. If the E&Y’s qualification is so ‘bleeding obvious’ then it must be bleeding obvious there is a serious question whether the sale could be booked as revenue for the financial year ending June 2006.

The auditor would have informed CMQ’s management, what document (remedies) is required for the sale to be acceptable as fulfilling the covenant and probably CMQ could not obtain them from Inviro who is disputing the sale. It is plain stupid to challenge posters to provide evidence the covenant is not satisfiedor to make dogmatic statements Starks has no case. It is not possible for the obvious reasons the sale document/evidences are not accessible to the public.

Production was the mother of all excuse for lack of sales until DW came up with his fanciful ‘more focus approach’ which has yet to see any sales reported in the accounts or announced. Without sales, where is the economy of scale?

There is no lack of circular thinking. Blame the journalists, incompetent share analysts, auditors and the big pharmas. You will have your chances to reward DW with tens of millions of free options. Is it not ironic, remind shareholders of Melrose doubled directors remunerations not that long ago?

Cheers